Literature DB >> 10552338

The application of immobilized polymyxin B fiber in the treatment of septic shock associated with severe acute pancreatitis: report of two cases.

Y Asanuma1, T Furuya, J Tanaka, T Sato, S Shibata, K Koyama.   

Abstract

The elimination of endotoxin by direct hemoperfusion over immobilized polymyxin B fiber (PMX-F) was carried out in two patients who developed septic shock associated with severe acute pancreatitis. Parameters such as blood pressure, body temperature, and plasma endotoxin level improved after PMX-F treatment, and the infected lesions were successfully and safely removed by surgery. Although an aggressive operative strategy of debridement with ultimate closure over drains is generally associated with low mortality in patients with this devastating disease, we often hesitate to perform this operation due to the poor condition of the patient in the acute period, with multiple organ failure and/or septic shock status, and also because of the difficulty in diagnosing the pancreatic infection. In this situation, endotoxin elimination using PMX-F is a useful tool for treating secondary pancreatic infections to help the patient recover in preparation for surgery, or for treating perioperative endotoxemia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10552338     DOI: 10.1007/bf02482269

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  20 in total

Review 1.  Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application.

Authors:  H Shoji; T Tani; K Hanasawa; M Kodama
Journal:  Ther Apher       Date:  1998-02

Review 2.  Current surgical management of severe intraabdominal infection.

Authors:  M Schein; A Hirshberg; M Hashmonai
Journal:  Surgery       Date:  1992-09       Impact factor: 3.982

3.  Pancreatic abscess and other pus-harboring collections related to pancreatitis: a review of 108 cases.

Authors:  C Bassi; S Vesentini; F Nifosì; R Girelli; M Falconi; A Elio; P Pederzoli
Journal:  World J Surg       Date:  1990 Jul-Aug       Impact factor: 3.352

4.  Improved survival in 45 patients with pancreatic abscess.

Authors:  A L Warshaw; G L Jin
Journal:  Ann Surg       Date:  1985-10       Impact factor: 12.969

5.  Treatment of severe intra-abdominal sepsis and/or necrotic foci by an 'open-abdomen' approach. Zipper and zipper-mesh techniques.

Authors:  J L Garcia-Sabrido; J M Tallado; N V Christou; J R Polo; E Valdecantos
Journal:  Arch Surg       Date:  1988-02

6.  Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice.

Authors:  J L Rothstein; H Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

7.  Endotoxemia in human septic shock.

Authors:  R L Danner; R J Elin; J M Hosseini; R A Wesley; J M Reilly; J E Parillo
Journal:  Chest       Date:  1991-01       Impact factor: 9.410

8.  Detection of circulating tumor necrosis factor after endotoxin administration.

Authors:  H R Michie; K R Manogue; D R Spriggs; A Revhaug; S O'Dwyer; C A Dinarello; A Cerami; S M Wolff; D W Wilmore
Journal:  N Engl J Med       Date:  1988-06-09       Impact factor: 91.245

9.  Pancreatic necrosis: results of necrosectomy, packing, and ultimate closure over drains.

Authors:  G Branum; J Galloway; W Hirchowitz; M Fendley; J Hunter
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

10.  Surgical treatment of acute necrotizing pancreatitis.

Authors:  C Wilson; C S McArdle; D C Carter; C W Imrie
Journal:  Br J Surg       Date:  1988-11       Impact factor: 6.939

View more
  2 in total

1.  Severity scoring systems for prognosis and efficacy of polymyxin B-immobilized fiber treatment for colonic perforation.

Authors:  Shuhei Komatsu; Takumi Shimomatsuya; Masayuki Nakajima; Susumu Ono; Kazuhiro Maruhashi
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

2.  Unusual interaction of a lipopolysaccharide isolated from Burkholderia cepacia with polymyxin B.

Authors:  Hirofumi Shimomura; Motohiro Matsuura; Shinji Saito; Yoshikazu Hirai; Yasunori Isshiki; Kazuyoshi Kawahara
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.